The pharmaceutical industry sent a letter to Congress this week that explained they could not let Medicare bargain on prices of medications for the millions of people they cover because it would give the government too much power.
The letter stated, “these dangerous policy experiments are not the answer” in response to the idea of negotiating medication costs on behalf of the American Medicare recipients.
Their suggestion instead was to address policies that focus on what Americans pay out of pocket- not how much the drugs cost.
While drug prices continue to be an issue in America, other developed countries have used the government to negotiate prices while citizens end up paying up to 2.56 times less than Americans.
Democrats are putting in the effort to add medical and dental coverage as well as negotiate drugs prices.
The response from the pharmaceutical industry is that the governments attempts at gaining control of pricing is a smokescreen to gain control and would diminish patients access to medications.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected]